Impax Asset Management Group’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Sell |
470,027
-70,000
| -13% | -$1.67M | 0.06% | 131 |
|
|
2025
Q1 | $13.4M | Hold |
540,027
| – | – | 0.08% | 124 |
|
|
2024
Q4 | $10.2M | Buy |
540,027
+69,424
| +15% | +$1.31M | 0.05% | 159 |
|
|
2024
Q3 | $7.08M | Buy |
470,603
+210,576
| +81% | +$3.17M | 0.03% | 198 |
|
|
2024
Q2 | $7.44M | Hold |
260,027
| – | – | 0.03% | 186 |
|
|
2024
Q1 | $7.6M | Buy |
260,027
+60,000
| +30% | +$1.75M | 0.03% | 196 |
|
|
2023
Q4 | $6.75M | Hold |
200,027
| – | – | 0.03% | 197 |
|
|
2023
Q3 | $6.14M | Hold |
200,027
| – | – | 0.03% | 194 |
|
|
2023
Q2 | $8.02M | Hold |
200,027
| – | – | 0.03% | 179 |
|
|
2023
Q1 | $8.16M | Hold |
200,027
| – | – | 0.03% | 170 |
|
|
2022
Q4 | $7.72M | Sell |
200,027
-70,000
| -26% | -$2.7M | 0.03% | 168 |
|
|
2022
Q3 | $14.4M | Hold |
270,027
| – | – | 0.07% | 131 |
|
|
2022
Q2 | $15.7M | Sell |
270,027
-15,000
| -5% | -$875K | 0.08% | 128 |
|
|
2022
Q1 | $21.8M | Buy |
285,027
+26,091
| +10% | +$1.99M | 0.09% | 121 |
|
|
2021
Q4 | $15.6M | Buy |
258,936
+58,909
| +29% | +$3.54M | 0.06% | 135 |
|
|
2021
Q3 | $11.2M | Buy |
200,027
+30,000
| +18% | +$1.68M | 0.05% | 147 |
|
|
2021
Q2 | $10.3M | Buy |
170,027
+45,027
| +36% | +$2.73M | 0.05% | 153 |
|
|
2021
Q1 | $8.76M | Buy |
+125,000
| New | +$8.76M | 0.04% | 149 |
|